182 related articles for article (PubMed ID: 38243242)
41. Renal epithelioid angiomyolipoma: Histopathologic review, immunohistochemical evaluation and prognostic significance.
Park JH; Lee C; Suh JH; Kim G; Song B; Moon KC
Pathol Int; 2016 Oct; 66(10):571-577. PubMed ID: 27595761
[TBL] [Abstract][Full Text] [Related]
42. [Hepatic epithelioid angiomyolipoma/PEComa and focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma].
Machado I; Marhuenda A; Trallero M; Caballero M; Santos J; Cruz J; Estevan R
Rev Esp Patol; 2019; 52(4):250-255. PubMed ID: 31530409
[TBL] [Abstract][Full Text] [Related]
43. Malignant renal epithelioid angiomyolipoma with liver metastasis after resection: a case report with multimodality imaging and review of the literature.
Vicens RA; Jensen CT; Korivi BR; Bhosale PR
J Comput Assist Tomogr; 2014; 38(4):574-7. PubMed ID: 24887578
[TBL] [Abstract][Full Text] [Related]
44. A suggestion for pathological grossing and reporting based on prognostic indicators of malignancies from a pooled analysis of renal epithelioid angiomyolipoma.
Zheng S; Bi XG; Song QK; Yuan Z; Guo L; Zhang H; Ma JH
Int Urol Nephrol; 2015 Oct; 47(10):1643-51. PubMed ID: 26271644
[TBL] [Abstract][Full Text] [Related]
45. Renal epithelioid angiomyolipoma: computed tomography manifestation and radiologic-pathologic correlation depending on different epithelioid component percentages.
Luo C; Liu Z; Gao M; Hu Q; He X; Xi Y; Cai F; Zhang R; Zeng X; Xiao N
Abdom Radiol (NY); 2022 Jan; 47(1):310-319. PubMed ID: 34664098
[TBL] [Abstract][Full Text] [Related]
46. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
47. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
48. [Malignant renal epithelioid angiomyolipoma (EAML): about a rare case].
Lasri A; Touzani MA; Lahyani M; Karmouni T; Elkhader K; Koutani A; Andaloussi AA
Pan Afr Med J; 2019; 33():64. PubMed ID: 31448026
[TBL] [Abstract][Full Text] [Related]
49. Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board.
Xavier CB; Link R; Abreu L; Bettoni F; Marson F; Galante PAF; Masotti C; Amano MT; de Molla V; Camargo AA; Asprino PF; Sabbaga J
Oncologist; 2023 Jul; 28(7):624-627. PubMed ID: 37159554
[TBL] [Abstract][Full Text] [Related]
50. Epithelioid angiomyolipoma in a child--a diagnostic dilemma.
Gupta RK; Sharma MC; Chitragar S; Sinha K; Agarwala S; Sharma R
Urology; 2014 Jun; 83(6):1394-7. PubMed ID: 24612755
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma.
Li W; Guo L; Bi X; Ma J; Zheng S
Int J Clin Exp Pathol; 2015; 8(8):9446-51. PubMed ID: 26464702
[TBL] [Abstract][Full Text] [Related]
52. Coexistence of renal epithelioid angiomyolipoma and clear cell carcinoma in patients without tuberous sclerosis.
Cao QH; Liu F; Xiao P; Tian XY; Li B; Li Z
Int J Surg Pathol; 2012 Apr; 20(2):196-200. PubMed ID: 21742645
[TBL] [Abstract][Full Text] [Related]
53. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
54. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
[TBL] [Abstract][Full Text] [Related]
55. Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome.
Etzold A; Schröder JC; Bartsch O; Zechner U; Galetzka D
Fam Cancer; 2015 Mar; 14(1):161-5. PubMed ID: 25226867
[TBL] [Abstract][Full Text] [Related]
56. Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Matzenbacher Bittar C; de Araújo Rocha YM; Vieira IA; Rosset C; Andreis TF; Sartor ITS; Artigalás O; Netto CBO; Alemar B; Macedo GS; Ashton-Prolla P
PLoS One; 2021; 16(9):e0251639. PubMed ID: 34529667
[TBL] [Abstract][Full Text] [Related]
57. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
Macedo GS; Araujo Vieira I; Brandalize AP; Giacomazzi J; Inez Palmero E; Volc S; Rodrigues Paixão-Côrtes V; Caleffi M; Silva Alves M; Achatz MI; Hainaut P; Ashton-Prolla P
Cancer Genet; 2016 Mar; 209(3):97-106. PubMed ID: 26823150
[TBL] [Abstract][Full Text] [Related]
58. PEComas: the past, the present and the future.
Martignoni G; Pea M; Reghellin D; Zamboni G; Bonetti F
Virchows Arch; 2008 Feb; 452(2):119-32. PubMed ID: 18080139
[TBL] [Abstract][Full Text] [Related]
59. Simultaneous diagnosis of liver PEComa in a family with known Li-Fraumeni syndrome: a case report.
Galera López MDM; Márquez Rodas I; Agra Pujol C; García Pérez Á; Velasco Sánchez E; Álvarez Álvarez R
Clin Sarcoma Res; 2020 Nov; 10(1):24. PubMed ID: 33292569
[TBL] [Abstract][Full Text] [Related]
60. A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor.
Prejac J; Dedić Plavetić N; Gotovac Jerčić K; Borovečki F
World J Surg Oncol; 2021 Aug; 19(1):254. PubMed ID: 34452612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
